Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics-Reference-Cited by-同舟云学术

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics

Published:2015-04-24 Issue:16 Volume:6 Page:14614-14624
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bollig-Fischer Aliccia¹²,Michelhaugh Sharon K.³²,Wijesinghe Priyanga¹²,Dyson Greg¹²,Kruger Adele⁴,Palanisamy Nallasivam⁵,Choi Lydia¹²,Alosh Baraa⁶,Ali-Fehmi Rouba⁶²,Mittal Sandeep¹³²

Affiliation:

1. Department of Oncology at Wayne State University, Detroit, Michigan, USA

2. Karmanos Cancer Institute, Detroit, Michigan, USA

3. Department of Neurosurgery at Wayne State University, Detroit, Michigan, USA

4. Department of Obstetrics/Gynecology at Wayne State University, Detroit, Michigan, USA

5. Henry Ford Health System, Detroit, Michigan, USA

6. Department of Pathology at Wayne State University, Detroit, Michigan, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulating Tumorigenicity and Cancer Metastasis through TRKA Signaling;Current Cancer Drug Targets;2024-03

2. A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?;Journal of Neuro-Oncology;2023-02-23

3. Tumor microenvironment and exosomes in brain metastasis: Molecular mechanisms and clinical application;Frontiers in Oncology;2022-10-20

4. EML4–NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review;Frontiers in Medicine;2022-04-28

5. Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier;Pharmaceutics;2021-09-10